Lv728
3640 积分 2021-09-07 加入
Dual-epitope targeting of TSLP to simultaneously block TSLPR and IL-7Rα with a Biparatopic nanobody
2小时前
已完结
Trends in the development of cellular and gene therapy in China
5小时前
已完结
Type 2 airway inflammation in COPD
3天前
已完结
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability
5天前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
11天前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
12天前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
12天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
13天前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
13天前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
14天前
已完结
皖公网安备34019202002308
